Function-oriented synthesis, step economy, and drug design - PubMed (original) (raw)
Review
doi: 10.1021/ar700155p. Epub 2007 Dec 27.
Affiliations
- PMID: 18159936
- DOI: 10.1021/ar700155p
Review
Function-oriented synthesis, step economy, and drug design
Paul A Wender et al. Acc Chem Res. 2008 Jan.
Abstract
This Account provides an overview and examples of function-oriented synthesis (FOS) and its increasingly important role in producing therapeutic leads that can be made in a step-economical fashion. Biologically active natural product leads often suffer from several deficiencies. Many are scarce or difficult to obtain from natural sources. Often, they are highly complex molecules and thus not amenable to a practical synthesis that would impact supply. Most are not optimally suitable for human therapeutic use. The central principle of FOS is that the function of a biologically active lead structure can be recapitulated, tuned, or greatly enhanced with simpler scaffolds designed for ease of synthesis and also synthetic innovation. This approach can provide practical access to new (designed) structures with novel activities while at the same time allowing for synthetic innovation by target design. This FOS approach has been applied to a number of therapeutically important natural product leads. For example, bryostatin is a unique natural product anticancer lead that restores apoptosis in cancer cells, reverses multidrug resistance, and bolsters the immune system. Remarkably, it also improves cognition and memory in animals. We have designed and synthesized simplified analogs of bryostatin that can be made in a practical fashion (pilot scale) and are superior to bryostatin in numerous assays including growth inhibition in a variety of human cancer cell lines and in animal models. Laulimalide is another exciting anticancer lead that stabilizes microtubules, like paclitaxel, but unlike paclitaxel, it is effective against multidrug-resistant cell lines. Laulimalide suffers from availability and stability problems, issues that have been addressed using FOS through the design and synthesis of stable and efficacious laulimalide analogs. Another FOS program has been directed at the design and synthesis of drug delivery systems for enabling or enhancing the uptake of drugs or drug candidates into cells and tissue. We have generated improved transporters that can deliver agents in a superior fashion compared with naturally occurring cell-penetrating peptides and that can be synthesized in a practical and step-economical fashion. The use of FOS has allowed for the translation of exciting, biologically active natural product leads into simplified analogs with superior function. This approach enables the development of synthetically innovative strategies while targeting therapeutically novel structures.
Similar articles
- Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization.
Feyen F, Cachoux F, Gertsch J, Wartmann M, Altmann KH. Feyen F, et al. Acc Chem Res. 2008 Jan;41(1):21-31. doi: 10.1021/ar700157x. Epub 2007 Dec 27. Acc Chem Res. 2008. PMID: 18159935 Review. - In vitro and in vivo anticancer activities of synthetic (-)-laulimalide, a marine natural product microtubule stabilizing agent.
Liu J, Towle MJ, Cheng H, Saxton P, Reardon C, Wu J, Murphy EA, Kuznetsov G, Johannes CW, Tremblay MR, Zhao H, Pesant M, Fang FG, Vermeulen MW, Gallagher BM Jr, Littlefield BA. Liu J, et al. Anticancer Res. 2007 May-Jun;27(3B):1509-18. Anticancer Res. 2007. PMID: 17595769 - Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
Ojima I. Ojima I. Acc Chem Res. 2008 Jan;41(1):108-19. doi: 10.1021/ar700093f. Epub 2007 Jul 31. Acc Chem Res. 2008. PMID: 17663526 Review. - Synthesis and structure-activity correlation of natural-product inspired cyclodepsipeptides stabilizing F-actin.
Tannert R, Milroy LG, Ellinger B, Hu TS, Arndt HD, Waldmann H. Tannert R, et al. J Am Chem Soc. 2010 Mar 10;132(9):3063-77. doi: 10.1021/ja9095126. J Am Chem Soc. 2010. PMID: 20148556 - Total synthesis and biological evaluation of 11-desmethyllaulimalide, a highly potent simplified laulimalide analogue.
Wender PA, Hilinski MK, Soldermann N, Mooberry SL. Wender PA, et al. Org Lett. 2006 Mar 30;8(7):1507-10. doi: 10.1021/ol060233g. Org Lett. 2006. PMID: 16562928
Cited by
- Molecular complexity as a driving force for the advancement of organic synthesis.
Wright BA, Sarpong R. Wright BA, et al. Nat Rev Chem. 2024 Oct;8(10):776-792. doi: 10.1038/s41570-024-00645-8. Epub 2024 Sep 9. Nat Rev Chem. 2024. PMID: 39251714 Review. - Path toward "Net Zero Organic Synthesis".
Mainkar PS, Chandrasekhar S. Mainkar PS, et al. ACS Omega. 2024 May 9;9(20):21686-21689. doi: 10.1021/acsomega.4c00948. eCollection 2024 May 21. ACS Omega. 2024. PMID: 38799370 Free PMC article. - Natural Product Synthesis in the 21st Century: Beyond the Mountain Top.
Shenvi RA. Shenvi RA. ACS Cent Sci. 2024 Feb 14;10(3):519-528. doi: 10.1021/acscentsci.3c01518. eCollection 2024 Mar 27. ACS Cent Sci. 2024. PMID: 38559299 Free PMC article. Review. - Dinuclear Zn-Catalytic System as Brønsted Base and Lewis Acid for Enantioselectivity in Same Chiral Environment.
Ayesha, Ashraf A, Arshad M, Sajid N, Rasool N, Abbas M, Nazeer U, Khalid M, Imran M. Ayesha, et al. ACS Omega. 2024 Feb 5;9(6):6074-6092. doi: 10.1021/acsomega.3c07446. eCollection 2024 Feb 13. ACS Omega. 2024. PMID: 38375498 Free PMC article. Review. - A divergent intermediate strategy yields biologically diverse pseudo-natural products.
Bag S, Liu J, Patil S, Bonowski J, Koska S, Schölermann B, Zhang R, Wang L, Pahl A, Sievers S, Brieger L, Strohmann C, Ziegler S, Grigalunas M, Waldmann H. Bag S, et al. Nat Chem. 2024 Jun;16(6):945-958. doi: 10.1038/s41557-024-01458-4. Epub 2024 Feb 16. Nat Chem. 2024. PMID: 38365941 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources